Institutional investors purchased a net $5.7 million shares of VICL during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 57.13% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EVENTIDE ASSET MANAGEMENT LLC Bought 1.7 Million shares of Vical Inc
BVF PARTNERS LP Bought 1.4 Million shares of Vical Inc
PERCEPTIVE ADVISORS LLC Bought 1.1 Million shares of Vical Inc